Import Alert 54-12 lets FDA detain foods and dietary supplements labeled as ginseng that are not made from Panax plants. Under U.S. law only Panax can be called ginseng, so "Siberian ginseng" made from Eleutherococcus senticosus is misbranded. Greens powders, capsules, extracts and herbal pastes are on it. The fix is the label: call it eleuthero.
Listed on 54-12? Send us the firm name, product and label. We correct the botanical name and prepare the removal request.
Get a 54-12 Case Review| Item | Import Alert 54-12 |
|---|---|
| Official title | DWPE of Foods Containing Ginseng That Fail to Properly Declare Ginseng |
| Type | DWPE with surveillance |
| Rule | Only herbs from the genus Panax may be called ginseng (2002 Farm Bill, section 403(u)) |
| Charge | Section 403(u), refusal under 801(a)(3); code SBGINSENG |
| Red List | 9 firms: Canada 3, Australia 2, China 2, Israel 1, Turkey 1 |
| Removal contact | Importalerts2@fda.hhs.gov |
Details follow the current text of Import Alert 54-12, published February 27, 2026.
Daily greens and superfood powder supplements.
Bulk extracts labeled Siberian ginseng.
Organic Siberian ginseng powder.
Siberian ginseng capsules.
Honey and herbal mix pastes labeled with ginseng.
Blended powder concentrates with ginseng and ashwagandha.
| Latin binomial | Common name |
|---|---|
| Eleutherococcus senticosus | Eleuthero (not ginseng) |
| Panax ginseng | Asian ginseng |
| Panax pseudoginseng var. japonica | Japanese ginseng |
| Panax pseudoginseng var. notoginseng | Tienchi ginseng |
| Panax quinquefolius | American ginseng |
These names come from 21 CFR 101.4(h). FDA examines the statement of identity, the Supplement Facts panel, the ingredient list and other label statements, for both bulk and retail products. See our supplement label review.
Send the FDA Division compliance office in the notice information showing the product is not misbranded under section 403(u), such as English documentation that the ingredient called ginseng is from a Panax species. If it is eleuthero, ask about relabeling under FDA supervision with the correct name.
Corrected labels and labeling that no longer call a non-Panax ingredient ginseng, or botanical identity documents showing the ingredient is Panax, so FDA has confidence future entries will comply. Email Importalerts2@fda.hhs.gov under RPM Chapter 9-8.
FDA's framework is in RPM Chapter 9-8; FDA removal guidance explains what a request should include.
Removal help for food and supplements.
Other misbranded foods.
New dietary ingredients.
Check claims and ingredient labeling.
Supplement registration and labeling.
FDA hold statuses and release steps.
We correct ginseng and eleuthero names across your labels and labeling and prepare the removal request. We are an independent compliance firm, not FDA or a law firm, and no one can guarantee FDA's decision.
Contact our specialists, email info@fdaregistrationassistance.com, or call +1 (928) 275-8333. Import alert removal · Supplement services · Contact.
Get a 54-12 Case ReviewFDA Registration Assistance is a private consulting firm, not FDA or any government agency. FDA registration is not FDA approval, clearance or certification.
Import Alert 54-12 is titled "Detention Without Physical Examination of Foods Containing Ginseng That Fail to Properly Declare Ginseng." It is a DWPE with surveillance alert.
Section 10806 of the 2002 Farm Bill says ginseng may be used as a common or usual name only for herbs or herbal ingredients from a plant in the genus Panax. It added section 403(u) to the FD&C Act.
No. Eleutherococcus is not Panax, so it may not be called ginseng, including Siberian ginseng. Use the Latin name Eleutherococcus senticosus or the common name eleuthero.
Yes. Section 403(u) applies to all foods, including dietary supplements.
The product appears misbranded because it or its ingredients are represented as ginseng but are not from the genus Panax. It is misbranded under section 403(u) and subject to refusal under section 801(a)(3). The code is SBGINSENG.
The statement of identity, Supplement Facts or Nutrition Facts, the ingredient list and other statements on the label or labeling. FDA examines both bulk and retail products.
Under 21 CFR 101.4(h): Panax ginseng is Asian ginseng, Panax quinquefolius is American ginseng, Panax pseudoginseng var. japonica is Japanese ginseng and var. notoginseng is Tienchi ginseng. Eleutherococcus senticosus is eleuthero.
Greens powders, Siberian ginseng extracts and powders, capsules, herbal pastes and powder concentrates.
Nine firms: three in Canada, two in Australia, two in China, one in Israel and one in Turkey.
Open Import Alert 54-12 and search the Red List by country and firm name. Each entry shows the product and the date it was added. Check before every shipment season, since the alert is updated often.
Yes. FDA can detain any food that appears to be represented as ginseng, for example Siberian ginseng, but is not from Panax.
Send the FDA Division compliance office in the notice English documentation showing the ingredient called ginseng is from a Panax species. If it is not, ask about relabeling under FDA supervision.
Show FDA the cause is fixed, usually with corrected labels and labeling, and email the request to Importalerts2@fda.hhs.gov. See RPM Chapter 9-8 and FDA removal guidance.
Removal petitions go to Importalerts2@fda.hhs.gov. The alert lists the Division of Import Operations at (301) 796-0356 or Imports@fda.hhs.gov, and HFP-OCE-Imports@fda.hhs.gov for food policy questions.
No. FDA makes every removal decision. We are an independent compliance firm, not FDA or a law firm. We help you build a complete, well-documented request.
Tell us what your company makes, sells, or distributes, where each product is manufactured or packed, your U.S. importer or buyer arrangement, label readiness, and target shipment date.
Submitting this inquiry does not purchase a service or authorize paid work. Our team can discuss the scope and required materials before you commission assistance. Fields marked with an asterisk are required.